FDA Inspection 1090395 — Hikma Pharmaceuticals USA INC.
The FDA completed an inspection of Hikma Pharmaceuticals USA INC. on April 16, 2019 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 16, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Columbus, OH (United States)